Company Profile

Company Name	Hakuryudo Co., Ltd.
Founded	March 30, 2016
Capital	¥8,000,000
CEO	Hiroshi Okawa, Representative Director
Head Office	Umeyama Bldg. 2F, 11-8 Shinsen-cho, Shibuya-ku, Tokyo 150-0045, Japan
Phone	+81-3-6416-1745
Affiliate	Scarecrow Inc. https://scarecrow-inc.jp/

Company History

Scarecrow Inc. / Hakuryudo Co., Ltd.
Representative Director: Hiroshi Okawa
Born 1964 in Chofu, Tokyo

Mar. 2004	Founded Scarecrow Ltd. (Kawasaki, Kanagawa)
Jun. 2004	Opened branch in Maruyamacho, Shibuya-ku
Jul. 2004	Began joint research with Nippon Veterinary and Animal Science University on "Adoptive Immunotherapy for Canine Cancer"
Oct. 2004	Launched animal supplement "Panphenon (S)"
Sep. 2007	Began joint research with Nippon Veterinary Life Science University on "Clinical Application for Canine Heart Disease"
Oct. 2007	Re-registered as Scarecrow Inc.
Dec. 2007	Obtained Management Innovation Plan from METI under the New Business Activity Promotion Act for "Animal Aging Control Screening"
Aug. 2009	Launched animal supplement "iPet (S)"
Oct. 2010	Established Animal Medical Coordinator Research Association
Nov. 2010	Established Animal Medical Research Association
Mar. 2011	Launched animal supplement "AHCC Liquid / ImmuFun"
Apr. 2012	Began joint research and sales of animal supplement "LPS Dr / Allernan" with Kagawa University School of Medicine
Jun. 2013	Launched animal supplement "Proteo GC / Anyokun"
Oct. 2013	Launched animal supplement "Mimitol"
Apr. 2014	Joined Natural Immunity Control Technology Association (METI-certified) as Scarecrow Inc.
Dec. 2014	Relocated head office to Shinsen-cho 11-8, Shibuya-ku
Aug. 2015	Began research with Hokkaido Pharmaceutical University on "Natural Immunity and Pantoea Agglomerans LPS"
Oct. 2015	Began research with National Institute of Technology, Nagaoka College on "Functional Analysis of Earthworm Powder"
Nov. 2015	Launched animal supplement "Tricha (S)"
Mar. 2016	Founded Hakuryudo Co., Ltd.
Apr. 2016	Began joint research with Nihon University College of Bioresource Sciences on "Clinical Application for Canine Heart Disease"
Nov. 2017	Launched scalp serum for hair growth "Tricho H" (Hakuryudo)
Oct. 2018	Obtained Patent No. 6227594 "Hair Growth-Promoting Composition and Formulation"
Feb. 2019	Began joint research with Mahidol University and Chulalongkorn University, Thailand on "Clinical Application for Canine Heart Disease"
May 2019	Obtained Patent No. 6530776 "FGF-7 or VEGF Production Promoter and Its Formulation"
Mar. 2020	Launched eyelash serum "Tricho Eye" (Hakuryudo)
Apr. 2020	Launched quasi-drug hair growth agent "Tricho A" (Hakuryudo)
Apr. 2021	Joined Natural Immunity Control Technology Association (METI-certified) as Hakuryudo Co., Ltd.